When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APTO - Aptose Biosciences nabs patent in Australia for CG-806
Aptose Biosciences Inc.
The Australian Patent Office has issued Aptose Biosciences (NASDAQ:APTO) Patent No. 2013371146 for CG-806, a pan-FLT3/pan-BTK multi-cluster kinase inhibitor developed for acute myeloid leukemia (AML), B cell and other hematologic malignancies. This small molecule is in-licensed from CrystalGenomics.
More news on: Aptose Biosciences Inc., Healthcare stocks news,